Abstract: The invention teaches the provocation or enhancement of angiogenesis in a subject via the administration of angiogenically active omega-3 polyunsaturated fatty acids. Especially preferred are eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA).
Type:
Grant
Filed:
March 7, 1988
Date of Patent:
November 7, 1989
Assignee:
Angio Medical Corporation
Inventors:
Ahmad R. Kamarei, Michael Klibaner, Denise Peton